Jobs / United States / Glaxosmithkline LLC

Glaxosmithkline LLC

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, RSV Vaccines

3 Locations Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Glaxosmithkline LLC paid sponsored hires in similar roles
1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, RSV Vaccines   Locations:  GSK HQ UK, New Oxford Street or USA - Upper Providence or Wavre, Belgium Reporting to: Executive Director & TA Head-Vaccines   The CPO organisation partners closely with R&D and Commercial to translate cutting-edge science into measurable health outcomes, grounded in the patient voice and external insights from healthcare systems and decision-makers worldwide. Joining CPO means working across the full product lifecycle and collaborating with diverse expert teams – from Patients & External Environment and Medical Planning to Data Generation, Scientific Communications, Medical Impact, Proactive Risk Ownership and Integrated Evidence Strategy – to ensure robust evidence, clear medical insight and responsible risk ownership shape strategy and execution at scale. It’s a highly visible, purpose-driven environment where your expertise can directly influence how innovative therapies are developed, communicated and used to improve lives around the world.   The role of Senior Director, Global Real-World Evidence & Health Outcomes Research (GRWE& HO) Lead is critical to achieving this ambition by ensuring that each vaccine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing.  The role is essential for the alignment of evidence with the requirements of customers responsible for marketing authorization, recommendation and reimbursement leading to successful patient access, product use and commercial success.   The role will serve as single point accountable lead for RSV vaccines, including stand alone and combination assets, in market and pre-launch.  The role will be a key member of the Global Real-World Evidence & Health Outcomes Research Vaccines LT and other relevant matrix leadership teams.  The Senior Director, Global Real-World Evidence & Health Outcomes Research Lead will be accountable for ensuring team members engage closely with medical and matrix stakeholders and partner effectively in data generation plan (DGP) planning, design, execution, translation, and dissemination for the asset.      Key Responsibilities include, but are not limited to:     • Provide leadership, management, and development of Data Generation book of work.  • Partner effectively with matrix stakeholders in planning and design of the DGP for the asset, drive disciplined execution of studies and activities, translate results, and disseminate data and research findings to all relevant internal and external stakeholders.  • Provide scientific leadership for best practice in real world evidence study methodologies, leveraging diverse methodological approaches to meet unique product challenges with innovative evidence solutions. • Drive innovation and inform ideas and options through effective engagement with external experts, clinical guideline groups, HTA agencies, methodology and policy forums, and by leveraging knowledge of the external policy and decision maker environment to enable more efficient evidence development for the asset across the lifecycle (e.g. discovery, launching and life cycle management assets) • Integrate excellent understanding of the evolving global NITAG bodies, clinical guidelines groups, policy decision makers and payer environment, including recommendation, reimbursement, pricing, and access associated with vaccines. • Lead discussions with key stakeholders on prioritization of evidence generation in order to meet business and customer needs. • Deliver the materials to inform internal governance decision making (e.g. Medical Review Board, etc) • Facilitate alignment and partners

Apply on employer site ↗